Lang & Schwarz Aktiengesellschaft (LUS1)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 15.50 |
|---|---|
| 52-week range | 14.35 – 29.70 |
| Return, 1 month / 3 months | −1.3% / −1.0% |
| Return, 1 year / 3 years | −7.1% / +177.6% |
| Trend | Below its 200-day average |
| RSI (14) | 48 |
| Volatility (1 year) | 41.6% |
| Worst drawdown (1 year) | -43.4% |
| Average daily value traded | 0.21M EUR |
| Dividend yield | 25.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lang & Schwarz Aktiengesellschaft is a German securities trading firm based in Düsseldorf. It runs an electronic trading platform and acts as a market maker, quoting prices for equities, bonds, funds and derivative products such as certificates and warrants. Its customers include retail investors and institutional clients who trade through its platform and through partner banks and brokers. The company also issues its own derivative securities and provides liquidity in these instruments.
Lang & Schwarz Aktiengesellschaft trades under the code LUS1 on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lang & Schwarz Aktiengesellschaft (LUS1) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 15.50 on 23 October 2026.
Its price-based Market X-Ray is 39 out of 100 (a weak price profile), ranking 493 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 7.1% and over the last three months it fell 1.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 17 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -17.8% | ||
| From 52-week high | -47.6% | ||
| Momentum | 36 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -1.0% | ||
| 6-month return | -30.1% | ||
| 12-month return, skipping the last month | -5.9% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.4% | ||
| Liquidity | 54 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.21M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 94 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 25.8% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | −1.3% |
| 3 months | −1.0% |
| 6 months | −30.1% |
| 1 year | −7.1% |
| 3 years | +177.6% |
| 5 years | −2.9% |
Signals
| 50-day / 200-day average | 16.27 / 18.86 |
|---|---|
| Golden / death cross (60 days) | Death, 59 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Aug 2026 | EUR 2.0000 |
| 8 Jul 2026 | EUR 2.0000 |
| 11 Jul 2025 | EUR 1.7500 |
| 5 Jul 2024 | EUR 0.5500 |
| 23 Jun 2023 | EUR 0.6400 |
| 1 Sep 2022 | EUR 1.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.